JUSTIN MCCORD: Open Payments
NPI 1861099061 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$613 in 30 payments from 9 companies in 2025. Trend: 2023 $468 · 2024 $269 · 2025 $613
Food & beverage: $613
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $212 |
| ABBVIE INC. | 5 | $86 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
| Corium, LLC | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 3 | $55 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| Luye Pharma (USA) Ltd. | 1 | $30 |
| Tris Pharma Inc | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Auvelity, VRAYLAR, REXULTI, Azstarys, COBENFY, HETLIOZ, ERZOFRI EXTENDED-RELEASE, Dyanavel XR.
Industry payments across TN — which companies pay providers there.
